{
    "LeadSponsorName": [
        "Aragon Pharmaceuticals, Inc.",
        "BioNTech SE",
        "Boston Scientific Corporation",
        "Eidos Therapeutics, a BridgeBio company",
        "BeiGene",
        "Genentech, Inc.",
        "RayzeBio, Inc.",
        "medac GmbH",
        "PTC Therapeutics",
        "Azidus Brasil",
        "Nektar Therapeutics",
        "Daiichi Sankyo, Inc.",
        "Abbott",
        "Mylan Inc.",
        "UCB Pharma",
        "Astellas Pharma Inc",
        "Recombio SL",
        "Janssen Research & Development, LLC",
        "Tobira Therapeutics, Inc.",
        "Apellis Pharmaceuticals, Inc.",
        "Viracta Therapeutics, Inc.",
        "Pfizer",
        "Boehringer Ingelheim",
        "Checkpoint Therapeutics, Inc.",
        "Shionogi",
        "Principia Biopharma, a Sanofi Company",
        "Atos Medical AB",
        "Vical",
        "NantCell, Inc.",
        "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.",
        "ColubrisMX",
        "R-Pharm",
        "Agenus Inc.",
        "Merrimack Pharmaceuticals",
        "Corcept Therapeutics",
        "Zodiac Produtos Farmaceuticos S.A.",
        "AbbVie (prior sponsor, Abbott)",
        "Recepta Biopharma",
        "EMD Serono",
        "Acerta Pharma BV",
        "Uni\u00e3o Qu\u00edmica Farmac\u00eautica Nacional S/A",
        "Crinetics Pharmaceuticals Inc.",
        "EMD Serono Research & Development Institute, Inc.",
        "Isarna Therapeutics GmbH",
        "Halozyme Therapeutics",
        "Guerbet",
        "CanariaBio Inc.",
        "Heidelberg Pharma AG",
        "Cryopraxis Criobiologia Ltda.",
        "Threshold Pharmaceuticals",
        "Immix Biopharma, Inc.",
        "Spectrum Pharmaceuticals, Inc",
        "Nereus Pharmaceuticals, Inc.",
        "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.",
        "Polyphor Ltd.",
        "Amgen",
        "Gilead Sciences",
        "AbbVie",
        "Inovio Pharmaceuticals",
        "Synta Pharmaceuticals Corp.",
        "Basilea Pharmaceutica",
        "Celgene",
        "Akeso",
        "Pierre Fabre Medicament",
        "Merck Sharp & Dohme LLC",
        "Sandoz",
        "Eurofarma Laboratorios S.A.",
        "Genmab",
        "CancerVax Corporation",
        "CSL Behring",
        "Sesen Bio, Inc.",
        "Brooklyn ImmunoTherapeutics, LLC",
        "HUYABIO International, LLC.",
        "Tularik",
        "Celldex Therapeutics",
        "Taiho Oncology, Inc.",
        "Shire",
        "Genzyme, a Sanofi Company",
        "Applied Biology, Inc.",
        "Clovis Oncology, Inc.",
        "Janssen Sciences Ireland UC",
        "Myovant Sciences GmbH",
        "Chiltern Pesquisa Clinica Ltda",
        "Ligand Pharmaceuticals",
        "Regeneron Pharmaceuticals",
        "Hoffmann-La Roche",
        "Seagen Inc.",
        "Xcovery Holding Company, LLC",
        "UCB BIOSCIENCES GmbH",
        "OBI Pharma, Inc",
        "Jazz Pharmaceuticals",
        "Alaunos Therapeutics",
        "Ultragenyx Pharmaceutical Inc",
        "Wyeth is now a wholly owned subsidiary of Pfizer",
        "Gamida Cell ltd",
        "AstraZeneca",
        "Tolmar Inc.",
        "Merck KGaA, Darmstadt, Germany",
        "Sumitomo Pharma America, Inc.",
        "pharmaand GmbH",
        "Janssen Pharmaceutica",
        "Janssen-Cilag Farmaceutica Ltda.",
        "Humanigen, Inc.",
        "Incyte Corporation",
        "Cogent Biosciences, Inc.",
        "R-Pharm International, LLC",
        "Human Genome Sciences Inc., a GSK Company",
        "bluebird bio",
        "Asahi Kasei Pharma America Corporation",
        "OSI Pharmaceuticals",
        "Debiopharm International SA",
        "Tesaro, Inc.",
        "Morphotek",
        "Lavilabor Natural Products Ltd",
        "Alexion",
        "Baxalta now part of Shire",
        "Geron Corporation",
        "Biogen",
        "Novo Nordisk A/S",
        "ApoPharma",
        "Scitech Produtos Medicos Ltda",
        "mAbxience Research S.L.",
        "Bristol-Myers Squibb",
        "Becton, Dickinson and Company",
        "AVEO Pharmaceuticals, Inc.",
        "Kronos Bio",
        "Mallinckrodt",
        "RECORDATI GROUP",
        "Eisai Inc.",
        "Ipsen",
        "OncoVerity, Inc.",
        "Advaxis, Inc.",
        "Algenis SpA",
        "Bioverativ Therapeutics Inc.",
        "NovoCure Ltd.",
        "PharmaMar",
        "Telios Pharma, Inc.",
        "Crist\u00e1lia Produtos Qu\u00edmicos Farmac\u00eauticos Ltda.",
        "Otsuka Pharmaceutical Development & Commercialization, Inc.",
        "Helsinn Healthcare SA",
        "Agios Pharmaceuticals, Inc.",
        "Sanofi",
        "Puma Biotechnology, Inc.",
        "Intercept Pharmaceuticals",
        "Janssen-Cilag Ltd.",
        "Abivax S.A.",
        "Eli Lilly and Company",
        "Active Biotech AB",
        "Arcus Biosciences, Inc.",
        "Biozeus Biopharmaceutical S.A.",
        "BioMarin Pharmaceutical",
        "F2G Biotech GmbH",
        "ISA Pharmaceuticals",
        "EOM Pharmaceuticals",
        "Exelixis",
        "Takeda",
        "Novartis Pharmaceuticals",
        "Bayer",
        "Libbs Farmac\u00eautica LTDA",
        "GlaxoSmithKline",
        "Loxo Oncology, Inc.",
        "Biocinese",
        "Astellas Pharma Global Development, Inc.",
        "Anthera Pharmaceuticals",
        "Janssen Scientific Affairs, LLC",
        "Millennium Pharmaceuticals, Inc.",
        "Novartis",
        "Celcuity, Inc.",
        "Janssen Vaccines & Prevention B.V.",
        "Janssen Pharmaceutica N.V., Belgium",
        "Immune Biosolutions Inc",
        "Kyowa Kirin, Inc.",
        "SciClone Pharmaceuticals",
        "ViiV Healthcare",
        "Telik",
        "Cellectar Biosciences, Inc.",
        "Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA",
        "Teva Branded Pharmaceutical Products R&D, Inc.",
        "Sophia Genetics SAS",
        "Kartos Therapeutics, Inc.",
        "Mirati Therapeutics Inc."
    ]
}